Published on
Last updated on
Webinar in cooperation with WVIB in Freiburg/Germany
On 05.05.2020, a webinar was held in cooperation with the trade association of industrial enterprises in Baden (German: Wirtschaftsverband Industrieller Unternehmen in Baden or WIVB).
Experiences were exchanged and Cisema presented news about the current situation in China and important changes in the rules for medical devices. One focus was the introduction of the UDI system in China on 01.10.2020 (link to UDI news) and the intention of market access to the Greater Bay Area via listing in Hong Kong (link to Greater Bay Area news). Over 20 WVIB members from the German MedTech industry, followed the webinar and were able to ask detailed questions afterwards.
Link to WVIB website here.
Connect with Cisema
With more than 20 years of experience and a team of over 100 specialists, Cisema helps global companies achieve compliance across Asia Pacific with confidence and accelerate market entry.
Stay Informed with Monthly News and Analysis
Stay informed with the latest regulatory changes, expert insights, and market opportunities across APAC, delivered straight to your inbox.
Related News
China Expands MRI Registration Requirements Under New 2026 Review Guideline
Manufacturers seeking MRI registration in China must meet expanded technical, software, and validation requirements.
China CMDE Releases New Review Documents for Oncology NGS & HLA-B*58:01 Reagents
The new documents clarify expectations for Tier III variants, companion diagnostic clinical evaluation, tissue and plasma registration, and HLA-B*58:01 analytical validation.
Taiwan Extends Cosmetic GMP Requirements to Nearly All Manufacturing Sites
As of July 1, 2026, Taiwan has completed its cosmetic GMP rollout, extending mandatory ISO 22716-based manufacturing standards to nearly all cosmetic factories